Streptozotocin-induced dynamic metabonomic changes in rat biofluids

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3423-3435

  Xu, Wenxin ^a,c   Wu, Junfang ^a   An, Yanpeng ^a   Xiao, Chaoni ^a,b   Hao, Fuhua ^a   Liu, Hongbing ^a   Wang, Yulan ^a   Tang, Huiru ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b NORTHWEST UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

1H NMR spectroscopy; diabetes; Metabonomics; multivariate data analysis; unsaturated fatty acids

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ALANINE; ARGININE; ASPARTIC ACID; CHOLINE; CITRIC ACID; CREATINE; CREATININE; FORMIC ACID; GLUCOSE; GLUTAMIC ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTIDINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LOW DENSITY LIPOPROTEIN; LYSINE; MONOUNSATURATED FATTY ACID; NITRIC OXIDE SYNTHASE; PHENYLALANINE; PROLINE; STREPTOZOCIN; THREONINE; TYROSINE; UNSATURATED FATTY ACID; VALINE; GLUCOSE BLOOD LEVEL;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CITRIC ACID CYCLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; LIPID METABOLISM; MALE; METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PLASMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TIME; URINE; ANIMAL; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLUCOSURIA; METABOLOME; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; GLYCOSURIA; MALE; METABOLOME; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84861813306     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300280t     Document Type: Article

References (70)

1. Roglic, G.; Unwin, N.; Bennett, P. H.; Mathers, C.; Tuomilehto, J.; Nag, S.; Connolly, V.; King, H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000 Diabetes Care 2005, 28 (9) 2130-2135
2. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 2004, 27 (1 Suppl) S5-S10
3. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004, 27 (5) 1047-1053
4. Nathan, D. M.; Cleary, P. A.; Backlund, J. Y.; Genuth, S. M.; Lachin, J. M.; Orchard, T. J.; Raskin, P.; Zinman, B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N. Engl. J. Med. 2005, 353 (25) 2643-2653
5. Holman, R. R.; Paul, S. K.; Bethel, M. A.; Matthews, D. R.; Neil, H. A. 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 2008, 359 (15) 1577-1589
6. Patel, A.; MacMahon, S.; Chalmers, J.; Neal, B.; Billot, L.; Woodward, M.; Marre, M.; Cooper, M.; Glasziou, P.; Grobbee, D.; Hamet, P.; Harrap, S.; Heller, S.; Liu, L.; Mancia, G.; Mogensen, C. E.; Pan, C.; Poulter, N.; Rodgers, A.; Williams, B.; Bompoint, S.; de Galan, B. E.; Joshi, R.; Travert, F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N. Engl. J. Med. 2008, 358 (24) 2560-2572
7. Gerstein, H. C.; Miller, M. E.; Byington, R. P.; Goff, D. C. J.; Bigger, J. T.; Buse, J. B.; Cushman, W. C.; Genuth, S.; Ismail-Beigi, F.; Grimm, R. H. J.; Probstfield, J. L.; Simons-Morton, D. G.; Friedewald, W. T. Effects of intensive glucose lowering in type 2 diabetes N. Engl. J. Med. 2008, 358 (24) 2545-2559
8. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 2011, 34 (Suppl 1) S11-S61
9. Maier, L. M.; Wicker, L. S. Genetic susceptibility to type 1 diabetes Curr. Opin. Immunol. 2005, 17 (6) 601-608
10. Thomson, G.; Valdes, A. M.; Noble, J. A.; Kockum, I.; Grote, M. N.; Najman, J.; Erlich, H. A.; Cucca, F.; Pugliese, A.; Steenkiste, A.; Dorman, J. S.; Caillat-Zucman, S.; Hermann, R.; Ilonen, J.; Lambert, A. P.; Bingley, P. J.; Gillespie, K. M.; Lernmark, A.; Sanjeevi, C. B.; Ronningen, K. S.; Undlien, D. E.; Thorsby, E.; Petrone, A.; Buzzetti, R.; Koeleman, B. P.; Roep, B. O.; Saruhan-Direskeneli, G.; Uyar, F. A.; Gunoz, H.; Gorodezky, C.; Alaez, C.; Boehm, B. O.; Mlynarski, W.; Ikegami, H.; Berrino, M.; Fasano, M. E.; Dametto, E.; Israel, S.; Brautbar, C.; Santiago-Cortes, A.; Frazer de Llado, T.; She, J. X.; Bugawan, T. L.; Rotter, J. I.; Raffel, L.; Zeidler, A.; Leyva-Cobian, F.; Hawkins, B. R.; Chan, S. H.; Castano, L.; Pociot, F.; Nerup, J. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis Tissue Antigens 2007, 70 (2) 110-127
11. Todd, J. A.; Bell, J. I.; McDevitt, H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus Nature 1987, 329 (6140) 599-604
12. Barratt, B. J.; Payne, F.; Lowe, C. E.; Hermann, R.; Healy, B. C.; Harold, D.; Concannon, P.; Gharani, N.; McCarthy, M. I.; Olavesen, M. G.; McCormack, R.; Guja, C.; Ionescu-Tirgoviste, C.; Undlien, D. E.; Ronningen, K. S.; Gillespie, K. M.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Bennett, S. T.; Clayton, D. G.; Cordell, H. J.; Todd, J. A. Remapping the insulin gene/IDDM2 locus in type 1 diabetes Diabetes 2004, 53 (7) 1884-1889
13. Marron, M. P.; Raffel, L. J.; Garchon, H. J.; Jacob, C. O.; Serrano-Rios, M.; Martinez Larrad, M. T.; Teng, W. P.; Park, Y.; Zhang, Z. X.; Goldstein, D. R.; Tao, Y. W.; Beaurain, G.; Bach, J. F.; Huang, H. S.; Luo, D. F.; Zeidler, A.; Rotter, J. I.; Yang, M. C.; Modilevsky, T.; Maclaren, N. K.; She, J. X. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups Hum. Mol. Genet. 1997, 6 (8) 1275-1282
14. Mandrup-Poulsen, T. The role of interleukin-1 in the pathogenesis of IDDM Diabetologia 1996, 39 (9) 1005-1029
15. Larsen, P. M.; Fey, S. J.; Larsen, M. R.; Nawrocki, A.; Andersen, H. U.; Kahler, H.; Heilmann, C.; Voss, M. C.; Roepstorff, P.; Pociot, F.; Karlsen, A. E.; Nerup, J. Proteome analysis of interleukin-1beta - induced changes in protein expression in rat islets of Langerhans Diabetes 2001, 50 (5) 1056-1063
16. Lyssenko, V.; Jonsson, A.; Almgren, P.; Pulizzi, N.; Isomaa, B.; Tuomi, T.; Berglund, G.; Altshuler, D.; Nilsson, P.; Groop, L. Clinical risk factors, DNA variants, and the development of type 2 diabetes N. Engl. J. Med. 2008, 359 (21) 2220-2232
17. Lu, H.; Yang, Y.; Allister, E. M.; Wijesekara, N.; Wheeler, M. B. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach Mol. Cell. Proteomics 2008, 7 (8) 1434-1451
18. Tang, H. R.; Wang, Y. L. Metabonomics: a revolution in progress Prog. Biophys. Biochem. 2006, 33 (5) 401-417
19. Nicholson, J. K.; Wilson, I. D. Opinion: understanding "global" systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discovery 2003, 2 (8) 668-676
20. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discovery 2002, 1 (2) 153-161
21. Nicholson, J. K.; Lindon, J. C.; Holmes, E. "Metabonomics" : understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
22. Griffin, J. L. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis Curr. Opin. Chem. Biol. 2003, 7 (5) 648-654
23. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Pattern recognition methods and applications in biomedical magnetic resonance Prog. Nucl. Magn. Reson. Spectrosc. 2001, 39 (1) 1-40
24. 1H NMR spectroscopy as a result of metabonomic screening of humans Analyst 2004, 129 (3) 259-264
25. Wang, Y.; Holmes, E.; Tang, H.; Lindon, J. C.; Sprenger, N.; Turini, M. E.; Bergonzelli, G.; Fay, L. B.; Kochhar, S.; Nicholson, J. K. Experimental metabonomic model of dietary variation and stress interactions J. Proteome Res. 2006, 5 (7) 1535-1542
26. 1H NMR spectroscopy in conjunction with multivariate data analysis J. Proteome Res. 2007, 6 (7) 2605-2614
27. Yap, I. K.; Clayton, T. A.; Tang, H.; Everett, J. R.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Charuel, C.; Lindon, J. C.; Nicholson, J. K. An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate J. Proteome Res. 2006, 5 (10) 2675-2684
28. Bundy, J. G.; Lenz, E. M.; Bailey, N. J.; Gavaghan, C. L.; Svendsen, C.; Spurgeon, D.; Hankard, P. K.; Osborn, D.; Weeks, J. M.; Trauger, S. A.; Speir, P.; Sanders, I.; Lindon, J. C.; Nicholson, J. K.; Tang, H. Metabonomic assessment of toxicity of 4-fluoroaniline, 3,5-difluoroaniline and 2-fluoro-4-methylaniline to the earthworm Eisenia veneta (rosa): Identification of new endogenous biomarkers Environ. Toxicol. Chem. 2002, 21 (9) 1966-1972
29. Nicholson, J. K.; O'Flynn, M. P.; Sadler, P. J.; Macleod, A. F.; Juul, S. M.; Sonksen, P. H. Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects Biochem. J. 1984, 217 (2) 365-375
30. Wang, C.; Kong, H. W.; Guan, Y. F.; Yang, J.; Gu, J. R.; Yang, S. L.; Xu, G. W. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis Anal. Chem. 2005, 77 (13) 4108-4116
31. Dumas, M. E.; Barton, R. H.; Toye, A.; Cloarec, O.; Blancher, C.; Rothwell, A.; Fearnside, J.; Tatoud, R.; Blanc, V.; Lindon, J. C.; Mitchell, S. C.; Holmes, E.; McCarthy, M. I.; Scott, J.; Gauguier, D.; Nicholson, J. K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc. Natl. Acad. Sci. U. S. A. 2006, 103 (33) 12511-12516
32. Li, M.; Wang, B. H.; Zhang, M. H.; Rantalainen, M.; Wang, S. Y.; Zhou, H. K.; Zhang, Y.; Shen, J.; Pang, X. Y.; Zhang, M. L.; Wei, H.; Chen, Y.; Lu, H. F.; Zuo, J.; Su, M. M.; Qiu, Y. P.; Jia, W.; Xiao, C. N.; Smith, L. M.; Yang, S. L.; Holmes, E.; Tang, H. R.; Zhao, G. P.; Nicholson, J. K.; Li, L. J.; Zhao, L. P. Symbiotic gut microbes modulate human metabolic phenotypes Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (6) 2117-2122
33. Martin, F. P. J.; Dumas, M. E.; Wang, Y. L.; Legido-Quigley, C.; Yap, I. K. S.; Tang, H. R.; Zirah, S.; Murphy, G. M.; Cloarec, O.; Lindon, J. C.; Sprenger, N.; Fay, L. B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; Nicholson, J. K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model Mol. Syst. Biol. 2007, 3, 112
34. Shaham, O.; Wei, R.; Wang, T. J.; Ricciardi, C.; Lewis, G. D.; Vasan, R. S.; Carr, S. A.; Thadhani, R.; Gerszten, R. E.; Mootha, V. K. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity Mol. Syst. Biol. 2008, 4, 214
35. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death Mol. Syst. Biol. 2008, 4, 167
36. Zhang, X.; Wang, Y.; Hao, F.; Zhou, X.; Han, X.; Tang, H.; Ji, L. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses J. Proteome Res. 2009, 8 (11) 5188-5195
37. Salek, R. M.; Maguire, M. L.; Bentley, E.; Rubtsov, D. V.; Hough, T.; Cheeseman, M.; Nunez, D.; Sweatman, B. C.; Haselden, J. N.; Cox, R. D.; Connor, S. C.; Griffin, J. L. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human Physiol. Genomics 2007, 29 (2) 99-108
38. Rees, D. A.; Alcolado, J. C. Animal models of diabetes mellitus Diabetic Med. 2005, 22 (4) 359-370
39. Lenzen, S. The mechanisms of alloxan- and streptozotocin-induced diabetes Diabetologia 2008, 51 (2) 216-226
40. Elsner, M.; Guldbakke, B.; Tiedge, M.; Munday, R.; Lenzen, S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin Diabetologia 2000, 43 (12) 1528-1533
41. 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats Anal. Biochem. 2008, 383 (1) 76-84
42. Oresic, M.; Simell, S.; Sysi-Aho, M.; Nanto-Salonen, K.; Seppanen-Laakso, T.; Parikka, V.; Katajamaa, M.; Hekkala, A.; Mattila, I.; Keskinen, P.; Yetukuri, L.; Reinikainen, A.; Lahde, J.; Suortti, T.; Hakalax, J.; Simell, T.; Hyoty, H.; Veijola, R.; Ilonen, J.; Lahesmaa, R.; Knip, M.; Simell, O. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes J. Exp. Med. 2008, 205 (13) 2975-2984
43. Junod, A.; Lambert, A. E.; Stauffacher, W.; Renold, A. E. Diabetogenic action of streptozotocin: relationship of dose to metabolic response J. Clin. Invest. 1969, 48 (11) 2129-2139
44. Xiao, C.; Hao, F.; Qin, X.; Wang, Y.; Tang, H. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization Analyst 2009, 134 (5) 916-925
45. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67 (5) 793-811
46. Dai, H.; Xiao, C.; Liu, H.; Tang, H. Combined NMR and LC-MS analysis reveals the metabonomic changes in Salvia miltiorrhiza Bunge induced by water depletion J. Proteome Res. 2010, 9 (3) 1460-1475
47. Dai, H.; Xiao, C.; Liu, H.; Hao, F.; Tang, H. Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge J. Proteome Res. 2010, 9 (3) 1565-1578
48. 1H NMR spectroscopic metabonomic studies Anal. Chem. 2005, 77 (2) 517-526
49. Johan, T.; Svante, W. Orthogonal projections to latent structures (O-PLS) J. Chemom. 2002, 16 (3) 119-128
50. Li, H.; Ni, Y.; Su, M.; Qiu, Y.; Zhou, M.; Qiu, M.; Zhao, A.; Zhao, L.; Jia, W. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats J. Proteome Res. 2007, 6 (4) 1364-1370
51. Fan, T. W. M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28 (1996) 161-219
52. Lubetzki, J. Physiological effects of insulin Pathol. Biol. 1966, 14 (9) 584-590
53. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus J. Clin. Invest. 1994, 94 (6) 2369-2376
54. David, A. B. Branched chain amino acids: (proceedings of branched chain amino acids, a session from the 2nd international symposium advances in clinical nutrition, May 1982) FEBS Lett. 1983, 164 (1) 203-203
55. Hollis, T. M.; Kern, J. A.; Enea, N. A.; Cosgarea, A. J. Changes in plasma histamine concentration in the streptozotocin-diabetic rat Exp. Mol. Pathol. 1985, 43 (1) 90-96
56. Gill, D. S.; Barradas, M. A.; Fonseca, V. A.; Dandona, P. Plasma histamine concentrations are elevated in patients with diabetes mellitus and peripheral vascular disease Metabolism 1989, 38 (3) 243-247
57. de Zwart, L. L.; Meerman, J. H.; Commandeur, J. N.; Vermeulen, N. P. Biomarkers of free radical damage applications in experimental animals and in humans Free Radical Biol. Med. 1999, 26 (1-2) 202-226
58. Suyama, K.; Akagawa, M.; Sasaki, T. Oxidative deamination of lysine residue in plasma protein from diabetic rat: alpha-dicarbonyl-mediated mechanism Int. Congr. Ser. 2002, 1245, 243-248
59. Wilcken, D. E.; Sim, A. S.; Wang, J.; Wang, X. L. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l -arginine on its metabolism Mol. Genet. Metab. 2007, 91 (4) 309-317
60. Altinova, A. E.; Arslan, M.; Sepici-Dincel, A.; Akturk, M.; Altan, N.; Toruner, F. B. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations J. Clin. Endocrinol. Metab. 2007, 92 (5) 1881-1885
61. Sosenko, J. M.; Kato, M.; Soto, R.; Goldberg, R. B. Plasma lipid levels at diagnosis in type 2 diabetic patients Diabetic Med. 1993, 10 (9) 814-819
62. Obrosova, I. G.; Stevens, M. J.; Lang, H. J. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy Pharmacology 2001, 62 (3) 172-180
63. Armstrong, R. B.; Ianuzzo, C. D. Decay of succinate dehydrogenase activity in rat skeletal muscle following streptozotocin injection Horm. Metab. Res. 1976, 8 (5) 392-394
64. Mackerer, C. R.; Mehlman, M. A.; Tobin, R. B. alpha-Oxoglutarate carboxylation in liver mitochondria from normal, alloxan diabetic and streptozotocin diabetic rats Proc. Soc. Exp. Biol. Med. 1972, 139 (1) 24-27
65. Tancrede, G.; Rousseau-Migneron, S.; Nadeau, A. Long-term changes in the diabetic state induced by different doses of streptozotocin in rats Br. J. Exp. Pathol. 1983, 64 (2) 117-123
66. Phipps, A. N.; Stewart, J.; Wright, B.; Wilson, I. D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity Xenobiotica 1998, 28 (5) 527-537
67. Marchesi, J. R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I. D.; Wang, Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease J. Proteome Res. 2007, 6 (2) 546-551
68. Tian, Y.; Zhang, L.; Wang, Y.; Tang, H. Age-related topographical metabolic signatures for the rat gastrointestinal contents J. Proteome. Res. 2011, 11 (2) 1397-1411
69. Xu, J.; Zhang, L.; Chou, A.; Allaby, T.; Belanger, G.; Radziuk, J.; Jasmin, B. J.; Miki, T.; Seino, S.; Renaud, J. M. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity Am. J. Physiol.: Endocrinol. Metab. 2008, 294 (2) E326-335
70. Thyssen, S.; Arany, E.; Hill, D. J. Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin Endocrinology 2006, 147 (5) 2346-2356